RSV Vaccine Safety Signals Raise Alarming Questions
A new peer-reviewed pharmacovigilance study published in Human Vaccines & Immunotherapeutics analyzed nearly 18,000 adverse event reports tied to the three FDA-approved RSV vaccines — Pfizer’s Abrysvo, GSK’s Arexvy, and Moderna’s mRESVIA. The results raise urgent concerns about vaccine safety, especially for seniors and pregnant women. A Pharmacovigilance Study with …
FDA Publishes New Drug Rejection Letters
The FDA has released another batch of drug rejection letters, following up on the 200 complete response letters (CRLs) made public earlier this summer. The newly disclosed documents, spanning 2024 and 2025, shed light on the agency’s reasoning behind several high-profile rejections, from psychedelic therapies to ultra-rare disease treatments. The …
Senator Mike Johnson Says Trump Was an FBI Informant in Epstein Case
A wave of political intrigue has emerged following remarks by House Speaker Mike Johnson. During a media exchange, Johnson stated that President Trump “was an FBI informant to try and take this stuff down” in reference to Jeffrey Epstein. The claim came as Johnson defended Trump’s use of the term …
Gallup: Support for Childhood Shots Falls Sharply Since 2001
In Gallup’s July 1–21 survey (n=1,010; ±4 pts), just 40% of U.S. adults say it’s “extremely important” for parents to vaccinate their children—down from 58% in 2019 and 64% in 2001. The “extremely/very important” share has fallen from 94% in 2001 to 69% today. Republicans account for most of the …
DOJ Weighs Trans Gun Ban After Minneapolis Shooting
In the days after the Aug. 27, 2025 shooting at Annunciation Catholic School in Minneapolis—an attack that killed two children and wounded more than a dozen others—senior Justice Department officials met to examine whether the government could bar transgender people from purchasing or possessing firearms. People familiar with the meetings …